This company listing is no longer active
BBS-Bioactive Bone Substitutes Oyj Future Growth
Future criteria checks 2/6
BBS-Bioactive Bone Substitutes Oyj's earnings are forecast to decline at 10.3% per annum while its annual revenue is expected to grow at 78.8% per year. EPS is expected to grow by 4.5% per annum.
Key information
-10.3%
Earnings growth rate
4.5%
EPS growth rate
| Biotechs earnings growth | 35.0% |
| Revenue growth rate | 78.8% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 21 Nov 2023 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2025 | 2 | -4 | -5 | -4 | 1 |
| 12/31/2024 | 0 | -5 | -4 | -4 | 1 |
| 12/31/2023 | N/A | -4 | 1 | -3 | 1 |
| 3/31/2023 | N/A | -3 | -3 | -3 | N/A |
| 12/31/2022 | N/A | -3 | -3 | -3 | N/A |
| 9/30/2022 | N/A | -3 | -3 | -3 | N/A |
| 6/30/2022 | N/A | -3 | -3 | -3 | N/A |
| 3/31/2022 | N/A | -3 | -3 | -3 | N/A |
| 12/31/2021 | N/A | -3 | -3 | -3 | N/A |
| 9/30/2021 | N/A | -3 | -3 | -3 | N/A |
| 6/30/2021 | N/A | -3 | -3 | -3 | N/A |
| 3/31/2021 | N/A | -3 | -3 | -3 | N/A |
| 12/31/2020 | N/A | -3 | -2 | -2 | N/A |
| 9/30/2020 | N/A | -2 | -2 | -2 | N/A |
| 6/30/2020 | N/A | -2 | -2 | -2 | N/A |
| 3/31/2020 | N/A | -2 | -2 | -2 | N/A |
| 12/31/2019 | N/A | -2 | -1 | -1 | N/A |
| 9/30/2019 | N/A | -2 | -1 | -1 | N/A |
| 6/30/2019 | N/A | -2 | -1 | -1 | N/A |
| 3/31/2019 | N/A | -1 | -2 | -2 | N/A |
| 12/31/2018 | N/A | 0 | -2 | -2 | N/A |
| 9/30/2018 | N/A | -1 | -2 | -2 | N/A |
| 6/30/2018 | N/A | -3 | -2 | -2 | N/A |
| 3/31/2018 | N/A | -4 | -2 | -1 | N/A |
| 12/31/2017 | N/A | -4 | -1 | -1 | N/A |
| 12/31/2016 | N/A | -1 | N/A | -1 | N/A |
| 12/31/2015 | N/A | -1 | N/A | 0 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: BONEHU0223 is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: BONEHU0223 is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: BONEHU0223 is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: BONEHU0223's revenue (78.8% per year) is forecast to grow faster than the Finnish market (2.7% per year).
High Growth Revenue: BONEHU0223's revenue (78.8% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if BONEHU0223's Return on Equity is forecast to be high in 3 years time